-

ixlayer Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance

HITRUST Risk-based, 2-year (r2) Certification validates ixlayer is committed to strong cybersecurity and meeting key regulations to protect sensitive data

SAN FRANCISCO--(BUSINESS WIRE)--ixlayer, a leading digital platform for healthcare innovation services, today announced the ixlayer platform residing at Amazon Web Services (AWS) has earned certified status by HITRUST for information security.

HITRUST Risk-based, 2-year (r2) Certified status demonstrates that the organization’s platform has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk. This achievement places ixlayer in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

"HITRUST is recognized as the gold standard for healthcare information security," says Vahid Kowsari, Chief Technology Officer at ixlayer. "Achieving this certification reinforces our commitment to providing secure, reliable, and trustworthy healthcare solutions to our customers."

“HITRUST Certification is globally recognized as validation that information security and privacy controls are effective and compliant with various regulations. HITRUST Certification is considered the gold standard because of the comprehensiveness and applicability of the control requirements, depth of the assurance process, and level of oversight that ensures accuracy,” said Jeremy Huval, Chief Innovation Officer, HITRUST. “Individually, each element exceeds most other programs, and collectively they make HITRUST Certification the most comprehensive, transparent, consistent, and highest quality assessment available.”

Learn more about ixlayer’s commitment to security at ixlayer.com/technology/ or request access to the HITRUST report by emailing security@ixlayer.com.

About ixlayer
People deserve easy, affordable access to the best healthcare available. ixlayer is the leading healthcare platform that seamlessly integrates with all systems and enables organizations to accelerate access to effective health testing solutions, all under their brand. We help organizations overcome barriers within the fragmented healthcare experience, creating a population that takes control of their health and resulting in an improved care continuum. The ixlayer infrastructure helps payers, retailers and biopharma organizations launch and scale health testing programs that accelerate speed to market and drive engagement and compliance, while improving brand loyalty.

Contacts

Press:
Laura O’Neill
laura.oneill@finnpartners.com
402-499-8203

ixlayer


Release Versions

Contacts

Press:
Laura O’Neill
laura.oneill@finnpartners.com
402-499-8203

More News From ixlayer

ixlayer Partners With Porter to Close Care Gaps and Improve Patient Outcomes

SAN FRANCISCO--(BUSINESS WIRE)--ixlayer, the leading platform for health testing, today announced a partnership with Porter, a leading care coordination company, to integrate ixlayer’s at-home testing and remote patient monitoring capabilities into Porter’s existing care coordination offerings. ixlayer will serve as the backbone of Porter’s infrastructure, enabling increased touchpoints during patient transitions from hospital to home, which will improve patient outcomes. “By joining forces wit...

ixlayer Prediabetes and Type 2 Diabetes Screening Tests Enable Retailers, Health Systems and Payers to Engage Early and More Frequently in Disease Prevention

SAN FRANCISCO--(BUSINESS WIRE)--ixlayer, the leading platform for health testing, today announced it will offer prediabetes and Type 2 diabetes screening tests to retail, health system and payer customers, underscoring the essential role of early screening and regular testing in preventing and managing these diseases. A new white paper highlights the significant prevalence of prediabetes and diabetes in the United States, and why regular testing is important to public health. “While there are r...

ixlayer Empowers BrightInsight, Curavit and Medable With Convenient Patient Health Testing Services

SAN FRANCISCO--(BUSINESS WIRE)--ixlayer, the leading platform for health testing, today announced the continued expansion of its collaborations with biopharma innovators. Adding to a growing list of relationships in the biopharma space, ixlayer supports advances in digital therapeutics and decentralized clinical trials (DCTs), with remote diagnostic testing capabilities that enable patient support and clinical research technologies to realize the full potential of their impact on patient care....
Back to Newsroom